The choroid layer plays a critical role in maintaining outer retinal health and is implicated in numerous vision-threatening diseases such as diabetic retinopathy, age-related macular degeneration, and diabetic macular edema. While Enhanced-Depth Imaging Optical Coherence Tomography (EDI-OCT) enables detailed visualization of the choroid, accurate manual segmentation remains timeconsuming and subjective. In this study, we introduce RFA-U-Net, a novel deep learning model designed for precise choroid segmentation in OCT images. Building upon RETFound—a foundation model pre-trained on 1.6 million retinal images—RFA-U-Net retains its encoder to leverage rich hierarchical feature representations while addressing its general-purpose segmentation limitations through three key innovations: (1) attention gates to dynamically emphasize choroid-specific features, (2) feature fusion strategies to maintain contextual integrity during decoding, and (3) standard U-Net up-convolutions to ensure accurate boundary reconstruction. Extensive experiments demonstrate that RFA-U-Net outperforms pre-trained CNN-U-Net variants and state-of-the-art (SOTA) choroidal segmentation models. Specifically, it achieves a Dice score of 95.04 ± 0.25% and a Jaccard index of 90.59 ± 0.30% on an independent test set, highlighting its superior accuracy and robustness, particularly in challenging clinical scenarios with variable OCT image quality. These findings underscore the potential of combining foundation models and attention mechanisms to advance precision and reliability in ophthalmic diagnostics, paving the way for scalable and efficient deployment in clinical and community-based screening settings.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis study did not receive any funding
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of National Healthcare Group Eye of Institute, Singapore, gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data AvailabilityAll data produced in the present study are available upon reasonable request to the authors corresponding authors
V. DATA AVAILABILITYContact the corresponding authors
Comments (0)